Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Second Chamber) of 2 March 2022 –  
Degode v EUIPO – Leo Pharma (Skinovea)

(Case T‑715/20) (
[1](#t-ECR_62020TJ0715_INF_EN_01-E0001)
)

(EU trade mark – Opposition proceedings – Application for the EU word mark Skinovea – Earlier national word mark SKINOREN – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EU) 2017/1001)

| 1. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 16, 17, 96) |

| 2. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Assessment of the likelihood of confusion – Determination of the relevant public – Attention level of the public  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 19, 22) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Similarity between the goods or services in question – Criteria for assessment – Complementary nature of the goods or services  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 24-26, 39, 52) |

| 4. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Similarity of the marks concerned – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 55, 56, 60, 89) |

| 5. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Similarity of the marks concerned – Assessment of the distinctive character of an element of which a trade mark is composed  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 58, 67) |

| 6. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Word marks Skinovea and SKINOREN  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 97-100) |

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Degode-Dermago Development GmbH to pay the costs. |

---

(
[1](#c-ECR_62020TJ0715_INF_EN_01-E0001)
) [OJ C 35, 1.2.2021](./../../../legal-content/EN/AUTO/?uri=OJ:C:2021:035:TOC).

[Top](#document1)